- +49 8153 9970930
- info@productsandfeatures.com
- Argelsrieder Feld 1a, 82234 Wessling, GERMANY
Menu
Meet us at TCT Boston from September 16 -19 in Hall A — 241
Proctoring / Physicians
Planning, case preparation and proctoring are the ABC’s of the strategy to obtain the best procedural results. In Products and Features we understand the importance of high quality proctoring in order to achieve an optimal and successful learning curve. That is why we count with the most valuable expertise and high-level skills of different KOLs around the world which are best-in-class Structural heart Cardiologists.
Tricvalve
Dr. Ignacio J. Amat-Santos, MD, PhD
Dr. Amat-Santos is the Director of the Interventional Cardiology Department of Hospital Clínico Universitario of Valladolid (Spain). He was trained in Cardiology in the same center, in Interventional Cardiology at Quebec Heart & Lung Institute (Canada), and, in Statistics for Health Sciences in Autonoma University of Barcelona (Spain). He obtained a research contract from “Instituto de Salud Carlos III” (Madrid, Spain) during which he obtained his PhD “cum laude” and the first national prize from Lair Foundation to his Thesis focused on the percutaneous treatment of aortic stenosis.
Currently, Dr. Amat-Santos, is Associate Professor of Cardiology in the Valladolid University of Medicine and his research is centered in the percutaneous treatment of valvular heart disease and new therapeutic alternatives for heart failure, with more than 100 articles published in high impact journals of this field.
Dr. Ignacio Cruz, MD, PhD
Dr. Cruz-Gonzalez is Professor of Medicine at the University of Salamanca and Chief of Interventional Cardiology of University Hospital of Salamanca (Spain). He was trained in Interventional Cardiology at the Massachusetts General Hospital, Harvard Medical School (Boston, US). Currently he is the president-elect of the Spanish Association of Interventional Cardiology of the Spanish Society of Cardiology and member of the Scientific Program and Congress Committee of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).
His research has been focused in structural heart diseases interventions with more than 150 articles published in peer-reviewed journals.
Dr. Angel Sanchez Recalde
Dr. Sánchez-Recalde now fulfills the position of Director of the Interventional Cardiology Unit of University Hospital Ramón y Cajal, Madrid (Spain), as well as being the Director of Interventional Cardiology Units of University Hospitals Sanitas Zarzuela and Moraleja, Madrid (Spain). He undertook his Medical Internship at the Department of Cardiology of La Paz University Hospital (Spain) and St George’s University Hospital (UK) (2002) and his Fellowship in Interventional Cardiology at La Paz University Hospital (Spain) (2003). He worked in the Interventional Cardiology Unit and held the position of the Director of the Adult Congenital Heart Disease Unit in La Paz University Hospital (Spain) (2004-2018).
He completed his PhD Cum Laude in 2017 from the University Autonoma of Madrid and he also obtained University Master’s in Design and Statistics in Health Sciences from the University Autonoma of Barcelona and University Master’s in Healthcare Administration and Management from IMF Business School and IUTA University. He also developed an important research work with more than 160 publications in peer-reviewed journals in the field of Structural and Congenital Heart Diseases, 25 book chapters, as well as 25 Awards for best works in scientific meetings. From 2016 he is Associate Editor of Revista Española de Cardiologia (Spanish Journal of Cardiology).
Dr. Omar Abdul Jawad
Dr. Omar is the physician assistant in interventional cardiology at the Germans Trias i Pujol University Hospital in Barcelona, Spain. He completed his residency in cardiology at the Vall Hebron University Hospital in Spain. Following the completion of fellowship in interventional cardiology at the Gregorio Marañón Universitary and Vall Hebron University hospitals, he obtained his PhD degree, Cum Laude, from the Autonomous University of Barcelona. He completed his trainning during two years at Laval Hospital (Quebec, Canada) under the supervision of Dr. Rodes-Cabau (structural heart interventions) and Dr Rinfret (chronic total occlusion interventions). Moreover, he holds a degree in the field of Clinical Research applied to health science.
Besides numerous publications, Dr. Omar has acted as reviewer of scientific journals such as Journal of American College of Cardiology, PLOS ONE, American Heart Journal, and Circulation.
Dr. Xavier Freixa
Dr. Xavier Freixa is an Interventional Cardiologist at the Hospital Clinic of Barcelona, University of Barcelona. Dr. Freixa has been trained in interventional cardiology at the Toronto General Hospital, University Health Network and the Montreal Heart Institute, University of Montreal. He has a major interest in complex percutaneous coronary interventions, structural heart and adult congenital diseases. Among the main areas of interest highlight some advanced percutaneous techniques like PVL repair, left atrial appendage occlusion, ASD/VSD occlusion, TAVI and mitral or tricuspid valve repair with the Mitra-Clip system.
Dr. Luis Nombela Franco MD, PhD
Dr. Luis Nombela-Franco is an Interventional Cardiologist and coordinator of structural heart interventions at Hospital Clínico San Carlos, Complutense University (Madrid, Spain). He was trained in Cardiology at the University Hospital Puerta de Hierro, (Spain) and in interventional cardiology at the Quebec Heart and Lung Institute, (Quebec, Canada). He received his MD and PhD from Autónoma University of Madrid in 2003 and 2016, respectively. Among the main areas of interest highlight structural heart interventions like TAVI, mitral and tricuspid percutaneous valve repair and ASD/PFO/PVL/LAA occlusion. In addition, his research has been focused on structural heart diseases interventions with more than 250 articles published in peer-reviewed journals.
Dr. Pilar Jimenez Quevedo
Dr. Pilar Jimenez Quevedo is a Consultant Interventional Cardiologist at Clinico San Carlos University Hospital in Madrid. She received her medical degree from the University of Navarra in 1997 and Doctor cum laude in Medicine from the Complutense University of Madrid (2007). She became a certified Cardiology Specialist after training at Clínico San Carlos University Hospital in Madrid in 2003. She obtained her Masters in Interventional Cardiology from the Complutense University of Madrid in 2005. Subsequently she completed a prestigious Research Fellowship at the Texas Heart Institute, Houston, USA between 2005-2006. Since 2006, she has been an Interventional Cardiology Consultant at Clínico San Carlos University Hospital in Madrid with a focus on both clinical and research activities. She is currently a Clinical Tutor of the Cardiology Resident training program. She is a Fellow of the European Society of Cardiology and served as a member of the board of directors of the Spanish Interventional Cardiology Society from 2015 to 2017. Her H index is 46. She has published 200 articles in indexed publications and more than 200 presentations at congresses. Since 2015, she has been responsible for the Spanish national TAVI registry.
Tavi
DR. KASPARAS BRIEDIS, MD, MSC
Dr. Briedis is a Structural Interventional Cardiologist at the Hospital of the Lithuanian University of Health Sciences Kaunas Clinics. In 2018, he was awarded a 12-month Fellowship Grant for Training in Structural Heart Interventions from the European Association of Percutaneous Cardiovascular Interventions (EAPCI). He was trained in structural heart interventions at the Liverpool Heart and Chest Hospital (Liverpool, UK), Humanitas Research Hospital (Milan, Italy) and Luzerner Kantonsspital (Lucerne, Switzerland).
In 2020, Dr. Briedis was awarded a Scholarship from the European Society of Cardiology (ESC) and the Ministry of Education and Science of the Republic of Lithuania for the Executive MSc studies in Health Economics, Outcomes and Management in Cardiovascular Sciences, and he gained his MSc degree in Health Economics and Management in 2022.
Dr. Briedis is a PhD Candidate with a research focus on the coronary artery physiology and microcirculation in patients diagnosed with severe aortic valve stenosis undergoing TAVI procedures. He is a Lecturer in Medicine at the Lithuanian University of Health Sciences, and his research is centered on new technologies and interventions for structural heart diseases. He has over 60 articles published in peer-reviewed journals.
our team
Our Team is guided by passion to develop solutions that transform patients’ lives and assist healthcare professionals provide the best care.
Locations
P+F Products + Features is headquartered in Vienna, Austria, and has operation facilities in Germany, Portugal, Spain, and Brazil.
News & Services
Press Releases, Publications and News, Downloads and Media of P+F Products + Features
Our Team is guided by passion to develop solutions that transform patients’ lives and assist healthcare professionals provide the best care. In our field we have a reputation for attracting and developing some of the brightest leaders in the medical technology industry. We understand that robust leadership is critical to achieving our goals and fulfilling our Mission to restore health and extend life. As a result, our leadership team reflects a group of diverse individuals with an unparalleled breadth and depth of experience.
Our Team is guided by passion to develop solutions that transform patients’ lives and assist healthcare professionals provide the best care. In our field we have a reputation for attracting and developing some of the brightest leaders in the medical technology industry. We understand that robust leadership is critical to achieving our goals and fulfilling our Mission to restore health and extend life. As a result, our leadership team reflects a group of diverse individuals with an unparalleled breadth and depth of experience.
Our Team is guided by passion to develop solutions that transform patients’ lives and assist healthcare professionals provide the best care. In our field we have a reputation for attracting and developing some of the brightest leaders in the medical technology industry. We understand that robust leadership is critical to achieving our goals and fulfilling our Mission to restore health and extend life. As a result, our leadership team reflects a group of diverse individuals with an unparalleled breadth and depth of experience.
Our Team is guided by passion to develop solutions that transform patients’ lives and assist healthcare professionals provide the best care. In our field we have a reputation for attracting and developing some of the brightest leaders in the medical technology industry. We understand that robust leadership is critical to achieving our goals and fulfilling our Mission to restore health and extend life. As a result, our leadership team reflects a group of diverse individuals with an unparalleled breadth and depth of experience.